Atlas Trials

Study of AZD1222 for the Prevention of COVID-19 in Japan

Clinical trial NCT04568031 · COMPLETED

Trial details

NCT number
NCT04568031
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-08-23
Primary completion
2021-11-22
Enrollment
256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.